← Back to catalogue

Anscare Scar Reduction Silicone Gel C+

FDA UDI

Class I (US FDA UDI)

by Benq Materials Corp.

Identity

Trade Name
Anscare Scar Reduction Silicone Gel C+ FDA UDI
Generic Name
Scar-management dressing, single-use FDA UDI
Device Name
Anscare Scar Reduction Silicone Gel C+ helps prevent and treat both existing and new scars like keloids and hypertrophic scars resulting from surgery, trauma, burns, etc. (External Use Only) FDA UDI
Model / Reference
SC201-2 FDA UDI
Description
Anscare Scar Reduction Silicone Gel C+ helps prevent and treat both existing and new scars like keloids and hypertrophic scars resulting from surgery, trauma, burns, etc. (External Use Only) FDA UDI

Identifiers

Primary DI / UDI-DI
14719745504324 FDA UDI
FDA Product Code
MDA FDA UDI
GMDN Term
Scar-management dressing, single-use FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
878.4025 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Scar-management dressing, single-use

Anscare Scar Reduction Silicone Gel C+ by Benq Materials Corp. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Scar-management dressing, single-use.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI b1b87ade-2cc1-4bae-b8d4-91f97cda8684 33 fields · synced May 30, 2026